Ruchita Sinha
InvestorGeneral Partner at AV8 Ventures · Board director at Brave Care
San Francisco Bay Area
Writes $500K – $5M checks · typically $2M
Find your path to Ruchita
219 people in our graph share verified history with Ruchita — schools, employers, funds. One of them is your warm intro.
About
Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechDigital HealthEnterprise SoftwareFintechHealthtechInsurTech
Board director at Brave CareYC S19
Intro paths
Brave Care went through Y Combinator (Summer 2019) — Ruchita sits on its board, so any YC alum in your network can reach them through the company's founders.
In turn, Ruchita can intro founders to Brave Care's investors below.
Brave Care's investors · 11
Co-founders at Brave Care
Experience
- ARTIS VenturesSenior Partnercurrent2025 — present
- AV8 VenturesVenture Partnercurrent2019 — presentSan Francisco Bay Area
- SanofiSr. Director of Investments2016 — 2019
- GE VenturesDirector, GE Ventures2013 — 2016Menlo Park, CA
- Pfizer PharmaceuticalsDirector, Strategy, Portfolio Management, and Commercial Operations2010 — 2013Greater New York City Area
- L.E.K. ConsultingSr. Consultant2007 — 2010Greater New York City Area
- MaxygenResearch Associate2001 — 2005San Francisco Bay Area
Skills & more
+12 more
Financial ModelingProduct DevelopmentCompetitive AnalysisStart-upsMarket AnalysisTechnology TransferMergers & AcquisitionsMedical DevicesStrategyStrategic PlanningPharmaceutical IndustryLife SciencesFrom Ruchita's professional profile.
Investments
Investor
AetionBiome AnalyticsClick TherapeuticsCommon SensingCurisiumEvidation HealthInozymeJiseki HealthOmada HealthScience 37Shennon Biotechnologies
Sources: the firm's website · curated public sources.
Colleagues at AV8 Ventures
Network1
Investors connected to Ruchita in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ruchita Sinha?
- Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.
- Where does Ruchita Sinha work?
- Ruchita Sinha is General Partner at AV8 Ventures and Board director at Brave Care.
- What does Ruchita Sinha invest in?
- Ruchita Sinha invests in AI & Machine Learning, Biotech, Digital Health, Enterprise Software, Fintech, Healthtech, InsurTech.
- What check size does Ruchita Sinha write?
- Ruchita Sinha typically writes checks of $500K – $5M.
- What companies has Ruchita Sinha invested in?
- Investments tracked here include Aetion, Biome Analytics, Click Therapeutics, Common Sensing, Curisium, Evidation Health, Inozyme, Jiseki Health, Omada Health, Science 37, Shennon Biotechnologies.
- Where did Ruchita Sinha go to school?
- Ruchita Sinha studied at The University of Chicago Booth School of Business (MBA, Finance and Entreprenuership); University of Wisconsin-Madison (Master of Science - MS, Cell/Cellular and Molecular Biology); Mount Holyoke College (BS, Biochemistry).
Same school
Also attended The University of Chicago Booth School of Business941
+ 935 more
Also attended University of Wisconsin-Madison621
+ 615 more
Also attended Mount Holyoke College41
+ 35 more
Shared employers
Also worked at Sanofi243
+ 237 more
Also worked at Pfizer Pharmaceuticals399
+ 393 more
Also worked at L.E.K. Consulting194
+ 188 more
Also worked at Maxygen10
+ 4 more











































)




















